99mTc标记PSMA配体用于前列腺癌淋巴结转移放射性引导手术的初步验证
本研究纳入6例术前PSMA PET/CT怀疑淋巴结转移的前列腺癌患者,术中24小时前注射[99mTc]Tc-PSMA-I&S进行放射性引导手术,离体测量单淋巴结摄取。结果显示肿瘤阳性与阴性样本的SUL中位数分别为3.5和0.26,差异显著(p<0.0001),ROC曲线下面积0.917(95%CI 0.89-0.95),SUL cutoff 1.1时灵敏度76.6%、特异度94.4%。
要点
- 离体单淋巴结水平[99mTc]Tc-PSMA-I&S摄取可区分肿瘤阳性与阴性淋巴结。
- SUL cutoff 1.1时灵敏度76.6%、特异度94.4%,AUC 0.917。
- 99mTc较111In具有更好的γ探头测量物理性能、可及性和更低的辐射暴露。
核心结论
- 离体分析单淋巴结水平[99mTc]Tc-PSMA-I&S摄取在放射性引导手术中区分肿瘤阳性与阴性淋巴结具有良好的诊断性能。
研究设计与样本
- 前瞻性初步验证研究,纳入6例术前PSMA PET/CT怀疑淋巴结转移的前列腺癌患者(4例挽救性淋巴结清扫,2例初次淋巴结清扫)。
- 术前24小时静脉注射[99mTc]Tc-PSMA-I&S,术中手动分离至单淋巴结水平,离体用高纯锗探测器测量摄取,以SUL进行ROC分析。
主要发现
- 73个亚区组织样本分离出498个单样本,最终组织病理学鉴定356个淋巴结、160个淋巴结转移和11个非淋巴结前列腺癌样本。
- 肿瘤阴性样本SUL中位数为0.26,肿瘤阳性样本为3.5,差异显著(p<0.0001)。
- ROC分析显示AUC为0.917(95%CI 0.89-0.95)。
关键数值与推荐
- 采用SUL cutoff 1.1时,灵敏度76.6%、特异度94.4%、阳性预测值89.4%、阴性预测值86.9%。
临床怎么用
- [99mTc]Tc-PSMA-I&S放射性引导手术有望辅助术中识别前列腺癌淋巴结转移,但需进一步验证。
局限性
- 样本量小(6例患者),为初步验证性研究。
- 仅为离体单淋巴结水平分析,未报告术中实时引导的效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Intraoperative identification of prostate cancer (PCa) lymph node (LN) metastases (LNM) detected by preoperative PSMA PET/CT may be facilitated by PSMA radio-guided surgery (RGS) with use of a γ-probe. Earlier we demonstrated excellent performance of the 111In-labelled PSMA ligand DKFZ-617 ([111In]In-PSMA-617) in RGS for ex situ distinction of LN vs LNM at lymphadenectomy (LA) at a single LN level. In comparison with indium-111, technetium-99m has better physical properties for γ-probe measurements, better availability and lower radiation exposure for patients and medical personnel. Against this background, we evaluated the uptake of 99mTc-PSMA-I&S ligand at the level of single LN and its power to discriminate between unaffected LN and LNM. METHODS: Six patients with PCa with the suspicion of LNM on preoperative PSMA-PET/CT underwent [99mTc]Tc-PSMA-I&S RGS (4 salvage LA, 2 primary LA) with intravenous injection of [99mTc]Tc-PSMA-I&S 24 h prior to surgery. Resected samples were isolated manually aiming at the level of single LN. Uptake measurements were done ex situ with a high-purity germanium detector. Receiver operating characteristic (ROC) analysis was performed based on [99mTc]Tc-PSMA-I&S uptake expressed as lean body mass standard uptake value (SUL). RESULTS: Separation of the tissue samples from 73 subregions resulted in 498 single samples. After final histopathology 356 LN, 160 LNM und 11 non-nodal PCa samples were identified. Median SUL of tumor-free samples (0.26) and samples with cancer (3.5) was significantly different (p < 0.0001). ROC analysis revealed an area under the curve (AUC) of 0.917 (95% CI 0.89-0.95). Using a SUL cutoff of 1.1, sensitivity, specificity, positive predictive value, and negative predictive values were 76.6%, 94.4%, 89.4% and 86.9%. CONCLUSION: Ex situ analysis of [99mTc]Tc-PSMA-I&S uptake at single LN level showed good diagnostic performance for the ex situ distinction of tumor-bearing vs tumor-free LN during RGS.
引用
- Mix M, Schultze-Seemann W, von Büren M, et al. 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle. EJNMMI Res. 2021. PMID: 33661414. doi:10.1186/s13550-021-00762-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。